Chongqing Pharscin Pharmaceutical Co., Ltd.

SZSE:002907.SZ

16.07 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q1
Revenue 185.462228.393176.285154.802172.916187.539223.493194.062164.642202.986200.8209.605205.735230.001257.53245.458208.96170.527215.494221.121213.758191.691169.175180.939188.386164.916151.317156.163158.627125.987160.9131.087
Cost of Revenue 93.3989.84488.69468.20580.01174.43888.1774.54566.75889.819102.15991.53594.398111.833150.21130.563108.02769.50683.56676.99781.34165.18253.99954.5267.91854.33450.65547.06354.49743.14661.55646.413
Gross Profit 92.072138.54987.59186.59792.906113.101135.323119.51797.884113.16798.642118.07111.337118.168107.32114.895100.932101.021131.929144.125132.417126.509115.176126.419120.468110.582100.662109.1104.1382.84299.34584.675
Gross Profit Ratio 0.4960.6070.4970.5590.5370.6030.6050.6160.5950.5580.4910.5630.5410.5140.4170.4680.4830.5920.6120.6520.6190.660.6810.6990.6390.6710.6650.6990.6560.6580.6170.646
Reseach & Development Expenses 11.25512.64528.71820.48814.76214.15219.91617.67812.2948.93416.3588.26110.496.61213.5389.4418.6314.8689.8126.4032.9646.3796.4662.7754.6071.4674.5071.4365.12904.0640
General & Administrative Expenses -7.05612.759-27.25532.707-7.18911.65-23.6127.959-5.7389.53-23.77123.597-3.9599.253-18.7199.903-3.42110.232-1710.685-4.4598.343-16.517.761-7.24410.23-14.5777.446-4.9947.716-12.4687.394
Selling & Marketing Expenses 65.68568.01352.98248.04956.77952.92975.02465.28751.27954.34578.85965.37159.23355.12863.81858.60553.76748.95572.63974.25171.46572.43470.27675.11768.49565.45465.65360.65165.22447.7361.56247.586
SG&A 74.63880.77225.72680.75749.5964.57951.41493.24745.54163.87555.08888.96855.27464.38145.09968.50950.34659.18755.63884.93667.00680.77753.76582.87861.25175.68451.07668.09760.2355.44649.09554.98
Other Expenses -0.3290.021-2.847-0.2360.0270.18139.611-16.92811.0060.3130.0270.0120.0530.0160.036-0.024-0.248-0.1530.07-0.204-0.1810.044-0.2370.3140.3292.0310.9270.087-0.0620.3574.5210.822
Operating Expenses 86.22291.85996.27480.50383.36778.912110.94193.99668.84173.122102.44582.72882.89171.53584.88977.00459.37264.38195.06688.91560.65289.22986.21766.94383.43177.75678.40754.81375.06857.35676.52156.853
Operating Income 5.8548.045-5.8724.55111.39735.74726.47620.83326.93834.582-1.59238.71123.55342.63925.53337.45241.54932.90335.62254.07771.73836.82628.88958.18638.6132.78622.75453.98630.13824.17420.90925.249
Operating Income Ratio 0.0320.21-0.0330.0290.0660.1910.1180.1070.1640.17-0.0080.1850.1140.1850.0990.1530.1990.1930.1650.2450.3360.1920.1710.3220.2050.1990.150.3460.190.1920.130.193
Total Other Income Expenses Net 5.7790.021-2.847-0.2360.0270.029-0.2190.05-0.173-0.2470.0273.381-4.839-3.9783.138-0.463-0.26-3.889-1.17-1.336-0.208-0.411-0.307-0.9761.9021.991.429-0.2141.029-0.9550.893-1.751
Income Before Tax 11.6348.066-8.7194.31511.42535.77626.25720.88426.76534.335-1.56438.72223.60742.65525.5737.42941.332.7535.69253.87371.55736.8728.65258.49938.93934.81623.68454.07330.09124.53123.71626.071
Income Before Tax Ratio 0.0630.21-0.0490.0280.0660.1910.1170.1080.1630.169-0.0080.1850.1150.1850.0990.1520.1980.1920.1660.2440.3350.1920.1690.3230.2070.2110.1570.3460.190.1950.1470.199
Income Tax Expense 2.277.7153.3570.9020.1635.6750.7040.014.1424.984-3.9085.5553.8126.1811.1635.4796.3164.9033.718.210.6975.6393.2968.7856.0875.3674.457.4385.6122.8914.8293.892
Net Income 6.86440.351-12.0763.41311.26230.10125.55420.87422.62329.3512.34433.16819.79536.47424.40631.9534.98527.84731.98245.67360.8631.23125.35649.71432.85229.44919.23346.63524.47921.63918.88722.179
Net Income Ratio 0.0370.177-0.0690.0220.0650.1610.1140.1080.1370.1450.0120.1580.0960.1590.0950.130.1670.1630.1480.2070.2850.1630.150.2750.1740.1790.1270.2990.1540.1720.1170.169
EPS 0.0160.097-0.0290.0080.0270.0720.0630.0520.0560.0730.0060.0830.0490.0910.0610.080.0870.070.080.110.150.0780.0630.120.0820.0740.0530.130.0680.060.0530.062
EPS Diluted 0.0160.097-0.0290.0080.0270.0720.0630.0520.0560.0730.0060.0830.0490.0910.0610.080.0870.070.080.110.150.0780.0630.120.0820.0740.0530.130.0680.060.0530.062
EBITDA 27.12349.667-11.8625.07610.73535.78627.02826.88131.01340.8230.77840.61130.80448.59527.1343.30643.81838.47538.04256.82472.05438.30329.68360.841.17234.424.77354.69328.94826.56441.98530.126
EBITDA Ratio 0.1460.217-0.0670.0330.0620.1910.1210.1390.1880.2010.0040.1940.150.2110.1050.1760.210.2260.1770.2570.3370.20.1750.3360.2190.2090.1640.350.1820.2110.2610.23